International ConferencesConference Provider | Allan Lloyds

Global Medical Affairs Summit


The activities of Medical Affairs in pharmaceutical companies are considered as a key component of a successful product launch. During the last few years, the scope of Medical Affairs has changed and become even more relevant, and it is very important to keep pace with this changing role. Join the Global Medical Affairs Summit, meet professionals from the best pharma companies and learn what the new trends in Medical Affairs are, how to maximise the value of RWE, the usage of data in medical affairs, the importance of patient centricity and patient outcomes, novelties in Medical Information, listen to some case studies about cross-collaboration, strategic partnerships, and many other topics. Do not miss the opportunity to exchange knowledge and experience with the best Medical Affairs professionals at the Global Medical Affairs Summit during 12 - 13 June 2019 in Berlin! 

Join us and register today

Stay on top of the latest trends

Key speakers

Klaus VIEL

Klaus VIEL

Head Global Medical Affairs Operations
Daniel KALANOVIC

Daniel KALANOVIC

Vice President, Global Medical Team Lead, Immuno-Oncology, Lung Cancer, Renal Cancer
Imane WILD

Imane WILD

Senior VP Global Head of Medical Affairs
Artur BAUHOFER

Artur BAUHOFER

Senior Director Corporate Medical Affairs
Christopher BURTON

Christopher BURTON

Section Head, Global Medical Affairs
Pierre-Henri BELIN

Pierre-Henri BELIN

Global Commercial Integration Head


Key topics

  • Data Management – How to use data to support the outsourcing and impact in medical affairs better?
  • Maximising the current & future value of Real Word Evidence
  • Investigator initiated trials (IITs) - exploring the field for new indications
  • Building a patient-focused strategy to launch a product
  • Transforming the product benefits into relevant insights for the patients
  • Cross-collaboration between medical affairs and other departments
  • How to improve the patient outcomes?
  • Opportunities for medical affairs in emerging markets
  • Compliance issues related to the MSL-KOL relationship



Who Should Attend

Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors, and Heads of departments from pharmaceutical industry/industries involved in:

  • Medical Affairs
  • Medical Science Liaisons (MSL)
  • Medical Information
  • Medical Writing
  • Medical and Scientific Communication 
  • Scientific Affairs
  • Real World Evidence
  • Commercial Excellence
  • Market Access 
  • KOL/Thought Leader Relations/Engagement
  • Clinical Affairs
  • Medical Review
  • Medical Directors
  • Health Economics and Outcomes Research/HEOR
  • Product Launch
  • Patient Outcomes
  • Patient Centricity
  • Digital Medical 
  • Customer Value
  • Scientific Engagement
  • Scientific Partnerships
  • Commercial Operations
  • External Affairs
  • Chief Medical Officer
  • Medical Affairs Operations
  • Medical Strategy
  • Policy & Market Access
  • Portfolio Planning
  • Launch Management
  • Medical/Scientific/Patient Communications
  • Scientific Information